[Factors associated with cardiovascular risk and cardiovascular and renal disease in the IBERICAN study: Final

S Cinza-Sanjurjo1, R M Micó-Pérez2, S Velilla-Zancada3

  • 1Centro de Salud de Porto do Son, AS Santiago de Compostela, Porto do Son, A Coruña, España.

Semergen
|September 3, 2020
PubMed

Insights

Cardiovascular risk factors (CVRF) and cardiovascular disease (CVD) are highly prevalent in Spanish primary care. These factors, along with renal disease, show strong causal relationships, highlighting the need for integrated management.

Area of Science:

  • Cardiology
  • Primary Care Medicine
  • Epidemiology

Background:

  • Cardiovascular risk factors (CVRF) and cardiovascular disease (CVD) pose a significant public health challenge.
  • Understanding the prevalence and interrelationships of CVRF and CVD in primary care is crucial for effective prevention and management.

Purpose of the Study:

  • To analyze the prevalence of CVRF and CVD in a primary care setting.
  • To investigate the causal relationships between CVRF, renal disease, and CVD.

Main Methods:

  • Cross-sectional analysis of 8,066 patients aged 18-85 from the IBERICAN study.
  • Data collected via medical history, analytics, and physician review.
  • Multivariate logistic regression analysis incorporating autonomous region as a random effect.

Main Results:

  • High prevalence of CVRF and CVD observed in the Spanish primary care population.
  • Significant associations found: dyslipidemia more frequent in diabetics (2.4x), hypertension more frequent in diabetics (2x).
  • CVD four times more frequent with family history; increased risk in women and patients with renal disease.

Conclusions:

  • The analyzed Spanish primary care population exhibits high CVRF and CVD prevalence, indicating substantial cardiovascular risk.
  • Multivariate analysis confirms strong causal links between CVRF, renal disease, and CVD.
Abstract

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
312
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
6.1K
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions01:09

Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions

Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
407
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels01:31

Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels

Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
463
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
319
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
647